In the research study, released in the journal Science Advances, 83 patients with an average age of 81 and all struggling with moderate to severe COVID-19 infection were given a drug called baricitinib.
Learn More
Arthritis drug may enhance COVID-19 survival among senior patients, says study
Byindianadmin
Nov 16, 2020